+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Esoteric Testing Market 2023-2027

  • PDF Icon

    Report

  • 153 Pages
  • September 2023
  • Region: Global
  • TechNavio
  • ID: 4755288
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The esoteric testing market is forecasted to grow by USD 18,872.17 mn during 2022-2027, accelerating at a CAGR of 11.51% during the forecast period. The report on the esoteric testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in new product launches, and increase in merger and acquisition activities.

The esoteric testing market is segmented as below:

By Type

  • Infectious disease
  • Endocrinology
  • Oncology
  • Immunology
  • Others

By End-user

  • Hospital laboratories
  • Clinical research laboratories and medical institutes
  • Reference laboratories

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing emphasis on expansions of esoteric testing facility as one of the prime reasons driving the esoteric testing market growth during the next few years. Also, increase in research and development activities and advent of automation and laboratory robotics will lead to sizable demand in the market.

The report on the esoteric testing market covers the following areas:

  • Esoteric testing market sizing
  • Esoteric testing market forecast
  • Esoteric testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading esoteric testing market vendors that include ATS GENETECH PVT. LTD., Bio Rad Laboratories Inc., Creative Biogene, Cytek Biosciences Inc., EMSL Analytical Inc., Enzo Biochem Inc., Intertek Group Plc, IQVIA Holdings Inc., Kindstar Globalgene Technology Inc., Laboratory Corp. of America Holdings, Machaon Diagnostics Inc., MedGenome Labs Ltd., Merck KGaA, Microbac Laboratories Inc., Miltenyi Biotec B.V. and Co. KG, Oncquest Laboratories Ltd., Rochester Regional Health, Sonic Healthcare Ltd., The University of Utah, and Yoda Diagnostics. Also, the esoteric testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global esoteric testing market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global esoteric testing market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 End-User Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-User Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Infectious disease - Market size and forecast 2022-2027
Exhibit 34: Chart on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Infectious disease - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Infectious disease - Year-over-year growth 2022-2027 (%)
6.4 Endocrinology - Market size and forecast 2022-2027
Exhibit 38: Chart on Endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Endocrinology - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Endocrinology - Year-over-year growth 2022-2027 (%)
6.5 Oncology - Market size and forecast 2022-2027
Exhibit 42: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
6.6 Immunology - Market size and forecast 2022-2027
Exhibit 46: Chart on Immunology - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Immunology - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Immunology - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Immunology - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Type
Exhibit 54: Market opportunity by Type ($ million)
Exhibit 55: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 56: Chart on End-user - Market share 2022-2027 (%)
Exhibit 57: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 58: Chart on Comparison by End-user
Exhibit 59: Data Table on Comparison by End-user
7.3 Hospital laboratories - Market size and forecast 2022-2027
Exhibit 60: Chart on Hospital laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Hospital laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Hospital laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Hospital laboratories - Year-over-year growth 2022-2027 (%)
7.4 Clinical research laboratories and medical institutes - Market size and forecast 2022-2027
Exhibit 64: Chart on Clinical research laboratories and medical institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Clinical research laboratories and medical institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Clinical research laboratories and medical institutes - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Clinical research laboratories and medical institutes - Year-over-year growth 2022-2027 (%)
7.5 Reference laboratories - Market size and forecast 2022-2027
Exhibit 68: Chart on Reference laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Data Table on Reference laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Chart on Reference laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Reference laboratories - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 72: Market opportunity by End-user ($ million)
Exhibit 73: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 111: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 112: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 113: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ million)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 ATS GENETECH PVT. LTD.
Exhibit 123: ATS GENETECH PVT. LTD. - Overview
Exhibit 124: ATS GENETECH PVT. LTD. - Product/Service
Exhibit 125: ATS GENETECH PVT. LTD. - Key offerings
12.4 Creative Biogene
Exhibit 126: Creative Biogene - Overview
Exhibit 127: Creative Biogene - Product/Service
Exhibit 128: Creative Biogene - Key offerings
12.5 Cytek Biosciences Inc.
Exhibit 129: Cytek Biosciences Inc. - Overview
Exhibit 130: Cytek Biosciences Inc. - Product/Service
Exhibit 131: Cytek Biosciences Inc. - Key offerings
12.6 IQVIA Holdings Inc.
Exhibit 132: IQVIA Holdings Inc. - Overview
Exhibit 133: IQVIA Holdings Inc. - Business segments
Exhibit 134: IQVIA Holdings Inc. - Key news
Exhibit 135: IQVIA Holdings Inc. - Key offerings
Exhibit 136: IQVIA Holdings Inc. - Segment focus
12.7 Kindstar Globalgene Technology Inc.
Exhibit 137: Kindstar Globalgene Technology Inc. - Overview
Exhibit 138: Kindstar Globalgene Technology Inc. - Product/Service
Exhibit 139: Kindstar Globalgene Technology Inc. - Key offerings
12.8 Laboratory Corp. of America Holdings
Exhibit 140: Laboratory Corp. of America Holdings - Overview
Exhibit 141: Laboratory Corp. of America Holdings - Business segments
Exhibit 142: Laboratory Corp. of America Holdings - Key news
Exhibit 143: Laboratory Corp. of America Holdings - Key offerings
Exhibit 144: Laboratory Corp. of America Holdings - Segment focus
12.9 Machaon Diagnostics Inc.
Exhibit 145: Machaon Diagnostics Inc. - Overview
Exhibit 146: Machaon Diagnostics Inc. - Product/Service
Exhibit 147: Machaon Diagnostics Inc. - Key offerings
12.10 MedGenome Labs Ltd.
Exhibit 148: MedGenome Labs Ltd. - Overview
Exhibit 149: MedGenome Labs Ltd. - Product/Service
Exhibit 150: MedGenome Labs Ltd. - Key offerings
12.11 Merck KGaA
Exhibit 151: Merck KGaA - Overview
Exhibit 152: Merck KGaA - Business segments
Exhibit 153: Merck KGaA - Key news
Exhibit 154: Merck KGaA - Key offerings
Exhibit 155: Merck KGaA - Segment focus
12.12 Microbac Laboratories Inc.
Exhibit 156: Microbac Laboratories Inc. - Overview
Exhibit 157: Microbac Laboratories Inc. - Product/Service
Exhibit 158: Microbac Laboratories Inc. - Key offerings
12.13 Miltenyi Biotec B.V. and Co. KG
Exhibit 159: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibit 160: Miltenyi Biotec B.V. and Co. KG - Product/Service
Exhibit 161: Miltenyi Biotec B.V. and Co. KG - Key offerings
12.14 Oncquest Laboratories Ltd.
Exhibit 162: Oncquest Laboratories Ltd. - Overview
Exhibit 163: Oncquest Laboratories Ltd. - Product/Service
Exhibit 164: Oncquest Laboratories Ltd. - Key offerings
12.15 Rochester Regional Health
Exhibit 165: Rochester Regional Health - Overview
Exhibit 166: Rochester Regional Health - Product/Service
Exhibit 167: Rochester Regional Health - Key offerings
12.16 Sonic Healthcare Ltd.
Exhibit 168: Sonic Healthcare Ltd. - Overview
Exhibit 169: Sonic Healthcare Ltd. - Business segments
Exhibit 170: Sonic Healthcare Ltd. - Key offerings
Exhibit 171: Sonic Healthcare Ltd. - Segment focus
12.17 The University of Utah
Exhibit 172: The University of Utah - Overview
Exhibit 173: The University of Utah - Product/Service
Exhibit 174: The University of Utah - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 175: Inclusions checklist
Exhibit 176: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 177: Currency conversion rates for US$
13.4 Research methodology
Exhibit 178: Research methodology
Exhibit 179: Validation techniques employed for market sizing
Exhibit 180: Information sources
13.5 List of abbreviations
Exhibit 181: List of abbreviations
Exhibits:
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global esoteric testing market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - End-User Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Type - Market share 2022-2027 (%)
Exhibits 31: Data Table on Type - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Infectious disease - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Infectious disease - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Endocrinology - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Endocrinology - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on Immunology - Market size and forecast 2022-2027 ($ million)
Exhibits 47: Data Table on Immunology - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Chart on Immunology - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on Immunology - Year-over-year growth 2022-2027 (%)
Exhibits 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 54: Market opportunity by Type ($ million)
Exhibits 55: Data Table on Market opportunity by Type ($ million)
Exhibits 56: Chart on End-user - Market share 2022-2027 (%)
Exhibits 57: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 58: Chart on Comparison by End-user
Exhibits 59: Data Table on Comparison by End-user
Exhibits 60: Chart on Hospital laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Data Table on Hospital laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Chart on Hospital laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Hospital laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 64: Chart on Clinical research laboratories and medical institutes - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Data Table on Clinical research laboratories and medical institutes - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Chart on Clinical research laboratories and medical institutes - Year-over-year growth 2022-2027 (%)
Exhibits 67: Data Table on Clinical research laboratories and medical institutes - Year-over-year growth 2022-2027 (%)
Exhibits 68: Chart on Reference laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Data Table on Reference laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Chart on Reference laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 71: Data Table on Reference laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 72: Market opportunity by End-user ($ million)
Exhibits 73: Data Table on Market opportunity by End-user ($ million)
Exhibits 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 77: Chart on Geographic comparison
Exhibits 78: Data Table on Geographic comparison
Exhibits 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 107: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 110: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 111: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 112: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 113: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 114: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 115: Market opportunity By Geographical Landscape ($ million)
Exhibits 116: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 117: Impact of drivers and challenges in 2022 and 2027
Exhibits 118: Overview on Criticality of inputs and Factors of differentiation
Exhibits 119: Overview on factors of disruption
Exhibits 120: Impact of key risks on business
Exhibits 121: Vendors covered
Exhibits 122: Matrix on vendor position and classification
Exhibits 123: ATS GENETECH PVT. LTD. - Overview
Exhibits 124: ATS GENETECH PVT. LTD. - Product/Service
Exhibits 125: ATS GENETECH PVT. LTD. - Key offerings
Exhibits 126: Creative Biogene - Overview
Exhibits 127: Creative Biogene - Product/Service
Exhibits 128: Creative Biogene - Key offerings
Exhibits 129: Cytek Biosciences Inc. - Overview
Exhibits 130: Cytek Biosciences Inc. - Product/Service
Exhibits 131: Cytek Biosciences Inc. - Key offerings
Exhibits 132: IQVIA Holdings Inc. - Overview
Exhibits 133: IQVIA Holdings Inc. - Business segments
Exhibits 134: IQVIA Holdings Inc. - Key news
Exhibits 135: IQVIA Holdings Inc. - Key offerings
Exhibits 136: IQVIA Holdings Inc. - Segment focus
Exhibits 137: Kindstar Globalgene Technology Inc. - Overview
Exhibits 138: Kindstar Globalgene Technology Inc. - Product/Service
Exhibits 139: Kindstar Globalgene Technology Inc. - Key offerings
Exhibits 140: Laboratory Corp. of America Holdings - Overview
Exhibits 141: Laboratory Corp. of America Holdings - Business segments
Exhibits 142: Laboratory Corp. of America Holdings - Key news
Exhibits 143: Laboratory Corp. of America Holdings - Key offerings
Exhibits 144: Laboratory Corp. of America Holdings - Segment focus
Exhibits 145: Machaon Diagnostics Inc. - Overview
Exhibits 146: Machaon Diagnostics Inc. - Product/Service
Exhibits 147: Machaon Diagnostics Inc. - Key offerings
Exhibits 148: MedGenome Labs Ltd. - Overview
Exhibits 149: MedGenome Labs Ltd. - Product/Service
Exhibits 150: MedGenome Labs Ltd. - Key offerings
Exhibits 151: Merck KGaA - Overview
Exhibits 152: Merck KGaA - Business segments
Exhibits 153: Merck KGaA - Key news
Exhibits 154: Merck KGaA - Key offerings
Exhibits 155: Merck KGaA - Segment focus
Exhibits 156: Microbac Laboratories Inc. - Overview
Exhibits 157: Microbac Laboratories Inc. - Product/Service
Exhibits 158: Microbac Laboratories Inc. - Key offerings
Exhibits 159: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibits 160: Miltenyi Biotec B.V. and Co. KG - Product/Service
Exhibits 161: Miltenyi Biotec B.V. and Co. KG - Key offerings
Exhibits 162: Oncquest Laboratories Ltd. - Overview
Exhibits 163: Oncquest Laboratories Ltd. - Product/Service
Exhibits 164: Oncquest Laboratories Ltd. - Key offerings
Exhibits 165: Rochester Regional Health - Overview
Exhibits 166: Rochester Regional Health - Product/Service
Exhibits 167: Rochester Regional Health - Key offerings
Exhibits 168: Sonic Healthcare Ltd. - Overview
Exhibits 169: Sonic Healthcare Ltd. - Business segments
Exhibits 170: Sonic Healthcare Ltd. - Key offerings
Exhibits 171: Sonic Healthcare Ltd. - Segment focus
Exhibits 172: The University of Utah - Overview
Exhibits 173: The University of Utah - Product/Service
Exhibits 174: The University of Utah - Key offerings
Exhibits 175: Inclusions checklist
Exhibits 176: Exclusions checklist
Exhibits 177: Currency conversion rates for US$
Exhibits 178: Research methodology
Exhibits 179: Validation techniques employed for market sizing
Exhibits 180: Information sources
Exhibits 181: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global esoteric testing market: ATS GENETECH PVT. LTD., Bio Rad Laboratories Inc., Creative Biogene, Cytek Biosciences Inc., EMSL Analytical Inc., Enzo Biochem Inc., Intertek Group Plc, IQVIA Holdings Inc., Kindstar Globalgene Technology Inc., Laboratory Corp. of America Holdings, Machaon Diagnostics Inc., MedGenome Labs Ltd., Merck KGaA, Microbac Laboratories Inc., Miltenyi Biotec B.V. and Co. KG, Oncquest Laboratories Ltd., Rochester Regional Health, Sonic Healthcare Ltd., The University of Utah, and Yoda Diagnostics.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing emphasis on expansions of esoteric testing facility.'
According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ATS GENETECH PVT. LTD.
  • Bio Rad Laboratories Inc.
  • Creative Biogene
  • Cytek Biosciences Inc.
  • EMSL Analytical Inc.
  • Enzo Biochem Inc.
  • Intertek Group Plc
  • IQVIA Holdings Inc.
  • Kindstar Globalgene Technology Inc.
  • Laboratory Corp. of America Holdings
  • Machaon Diagnostics Inc.
  • MedGenome Labs Ltd.
  • Merck KGaA
  • Microbac Laboratories Inc.
  • Miltenyi Biotec B.V. and Co. KG
  • Oncquest Laboratories Ltd.
  • Rochester Regional Health
  • Sonic Healthcare Ltd.
  • The University of Utah
  • Yoda Diagnostics